Pharmotech is a Swiss Laboratory of Phyto research and his focus is research and development (R&D) on the pharmacological antibacterial and others potential applications of the active principles produced by plants, especially by the Cannabis Sativa plant.
The patent on CBD (cannabidiol) as antibacterial and anti-inflammatory we own on MDR bacteria, is a proof of evidence of our ability.
Pharmotech SA will become in the next years the only leading company in the world, producing and distributing medical product based on cannabinoids with the application of: prevent and cure gramMDR bacterias infections.
Pharmotech’s strategy is based on establishing a vertically integrated “Pharma” business model, with full traceability, building operations across all parts of the supply chain, including production operations, development of new drug-products.
If you have any question feel free to contact us at any time at firstname.lastname@example.org, or just click here.